1. Stocks
  2. Piramal Pharma Ltd.
  3. Swot
swot-logo

Piramal Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Piramal Pharma Ltd. has 16 Strengths, 8 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Promoter decreasing their shareholding

PE higher than Industry PE

High PE (PE > 40)

Declining Net Cash Flow : Companies not able to generate net cash

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

Stocks Underperforming their Industry Price Change in the Quarter

Brokers upgraded recommendation or target price in the past three months

Street Favorite: High Analyst Rating with at least 20% upside

Highest FII stock holdings

MFs decreased their shareholding last quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)